Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.09 USD | -0.27% | -5.38% | -22.50% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.50% | 203M | |
+27.66% | 443B | |
+31.29% | 276B | |
+11.47% | 145B | |
+8.29% | 93.11B | |
+26.22% | 90.17B | |
+63.95% | 61.13B | |
+13.37% | 46.32B | |
+23.05% | 35.73B | |
-12.92% | 31.13B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Roth MKM Adjusts Price Target on OptimizeRx to $20 From $31, Maintains Buy Rating